Search
Menu
CASTECH INC - New Building the Bridge of Light

Cornell Conducts OptoVision Trials

Facebook X LinkedIn Email
ORLANDO, Fla., Feb. 24 -- SurgiLight Inc., which develops laser systems for ophthalmic applications, said clinical trials of its OptiVision technology have shown promising early results for the reversal and treatment of presbyopia, a progressive stiffening of the eye's lens that occurs with aging and compromises an individual's near vision or ability to read without glasses. The trials were conducted at New York-Presbyterian Hospital Weill Cornell Medical Center, the first facility in the New York City area to offer the new treatment. According to Sandra Belmont, M.D., the trial's principal...Read full article

Related content from Photonics Media

    Published: February 2003
    News & Features

    We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.